Carcinoma
A brief digest about this topic
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Treatment plans may include surgery, radiation and/or chemotherapy.
NIH: National Cancer Institute
Provided by: NIH - National Institute of Health
Links shared publicly online about this topic
Adrenocortical Carcinoma
webmd.com — “Adrenocortical carcinoma is a rare tumor that affects only 1 to 2 persons per one million population. It usually occurs in adults,and the median age at diagnosis is 44 years. Although adrenal carcinoma is potentially curable at early stages,only 30% of these malignancies are confined to the adrenal gland at the time of diagnosis.[ 1 ] Radical surgical excision is the treatment of choice for ...” View full resource at webmd.com
Most Recently Shared on September 10, 2010 at 10:08 pm By:
Adrenocortical Carcinoma - What is adrenocortical carcinoma? http://bit.ly/cIHYcN
Carcinoma on #MDlinx
mdlinx.com — “Carcinoma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 22, 2010 at 3:37 pm By:
Social support and survival in young women with breast carcinoma: Psycho-Oncology http://bit.ly/aeS6w1 #OBG
Oncology Article | Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells” View full resource at mdlinx.com
Most Recently Shared on November 3, 2010 at 12:46 pm By:
Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells: Journal of Hematology ... http://bit.ly/9LPeTk #oncology
Oncology Article | Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis” View full resource at mdlinx.com
Most Recently Shared on September 9, 2011 at 6:47 am By:
Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis: On... http://t.co/i8SzAuB #oncology
Oncology Article | Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma” View full resource at mdlinx.com
Most Recently Shared on June 29, 2011 at 10:04 am By:
Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma... http://bit.ly/kxvrqf #oncology
Progestins Carcinoma Carcinoma, Endometrioid on #MDlinx
mdlinx.com — “Progestins Carcinoma Carcinoma, Endometrioid on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 1, 2010 at 10:07 am By:
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers an... http://bit.ly/boWaDD #oncology
Oncology Article | Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma” View full resource at mdlinx.com
Most Recently Shared on June 23, 2011 at 8:05 am By:
Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carci... http://bit.ly/kUHuDu #oncology
Oncology Article | Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma” View full resource at mdlinx.com
Most Recently Shared on May 20, 2011 at 10:00 am By:
Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with adva... http://bit.ly/mayOLw #oncology
Oncology Article | Carcinoma Carcinoma, Endometrioid
mdlinx.com — “The adult stem cell marker musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via notch-1 and p21WAF1/CIP1” View full resource at mdlinx.com
Most Recently Shared on December 20, 2010 at 6:42 am By:
The adult stem cell marker musashi-1 modulates endometrial carcinoma cell cycle progression and apopto... http://bit.ly/feVLfY #oncology
Oncology Article | Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Phase II trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma” View full resource at mdlinx.com
Most Recently Shared on January 31, 2011 at 7:49 am By:
Phase II trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular c... http://bit.ly/eC1S9r #oncology
Oncology Medical News about Carcinoma Carcinoma, Ductal Carcinoma, Ductal, Breast
mdlinx.com — “Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: Matched case-control study” View full resource at mdlinx.com
Most Recently Shared on March 25, 2010 at 6:03 am By:
Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and in... http://bit.ly/9nxmYY #HemeOnc
Oncology Article | Carcinoma Carcinoma, Ductal, Breast Carcinoma in Situ
mdlinx.com — “Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ” View full resource at mdlinx.com
Most Recently Shared on August 17, 2011 at 11:55 am By:
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ: The Breast http://t.co/5Xd3gTj #oncology
Oncology Article | Survival Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II” View full resource at mdlinx.com
Most Recently Shared on February 11, 2011 at 8:34 am By:
Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II: Medical Oncology http://bit.ly/eEQDnL #oncology
Gastroenterology Article | Biological Markers Carcinoma Carcinoma, Hepatocellular
mdlinx.com — “Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma” View full resource at mdlinx.com
Most Recently Shared on September 2, 2011 at 12:44 am By:
Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma: The Oncologist http://t.co/SkSSzTr #GI
Oncology Article | Carcinoma in Situ Carcinoma, Ductal
mdlinx.com — “Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ” View full resource at mdlinx.com
Most Recently Shared on January 10, 2011 at 6:50 am By:
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ: International J... http://bit.ly/fqCriB #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

